What is the approximate range of the actual price of ibrutinib/ibrutinib?
Ibrutinib/Ibrutinib (Ibrutinib) is an original research and development targeted drug. It is sold in the domestic market in the form of Yike capsules, with specifications of 140mg*90 capsules. The domestic selling price is about RMB 10,000 per box, and the specific price may vary depending on the hospital and region. It is worth noting that ibrutinib has been included in the scope of medical insurance, and eligible patients can be reimbursed through medical insurance, reducing the proportion of out-of-pocket expenses and making long-term treatment more economically feasible.

In overseas markets, the price of ibrutinib is relatively high. The price of each box of original drugs in Europe and the United States may exceed more than 10,000 US dollars, which fluctuates greatly due to exchange rates and policies. Therefore, for domestic patients, the cost of obtaining original drugs through formal overseas channels is relatively high. At the same time, there are various specifications of generic drugs in the overseas market, such as 140 mg 112 pills or 140 mg 120 pills, produced by manufacturers such as Lucius Pharmaceuticals in Laos. The price per box is about more than 1,000 yuan, which is basically the same as the original drug in terms of ingredients, but the price is significantly lower than the original drug, providing patients with an economically feasible alternative.
The existence of price differences requires patients to comprehensively consider drug sources, affordability, and efficacy when choosing treatment options. Although generic drugs are low in price, it is still necessary to pay attention to production qualifications, drug quality and legality to ensure safety and effectiveness. Domestic original drugs are reimbursed by medical insurance, which can reduce the proportion of patients paying out-of-pocket, and drug quality and medication management are more standardized, making them suitable for long-term maintenance treatment.
Taken together, the price of ibrutinib varies greatly in domestic and foreign markets. However, regardless of whether they choose the original drug or a generic drug, patients need to use it under the guidance of a doctor, maintain regular medication and regular follow-up visits to ensure efficacy and safety. By rationally selecting drug sources and medical insurance reimbursement strategies, patients can achieve efficient, economical, and safe long-term treatment.
Reference materials:https://www.imbruvica.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)